Eris Lifesciences Limited (BOM: 540596)
India
· Delayed Price · Currency is INR 1,378.25
0.00 (0.00%)
At close: Dec 20, 2024
Eris Lifesciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 19, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 187,867 | 114,719 | 77,801 | 93,615 | 82,147 | 50,089 | Upgrade
|
| Market Cap Growth | 52.17% | 47.45% | -16.89% | 13.96% | 64.00% | -43.52% | Upgrade
|
| Enterprise Value | 216,846 | 121,268 | 80,085 | 92,600 | 80,183 | 47,913 | Upgrade
|
| Last Close Price | 1378.25 | 841.20 | 572.05 | 681.83 | 593.31 | 358.16 | Upgrade
|
| PE Ratio | 53.91 | 29.27 | 20.36 | 23.05 | 23.13 | 16.89 | Upgrade
|
| PS Ratio | 7.30 | 5.76 | 4.68 | 7.06 | 6.89 | 4.73 | Upgrade
|
| PB Ratio | 5.71 | 3.56 | 3.50 | 4.91 | 5.21 | 3.86 | Upgrade
|
| P/TBV Ratio | - | - | - | 8.10 | 10.28 | 9.93 | Upgrade
|
| P/FCF Ratio | 30.58 | 32.15 | - | 36.39 | 23.50 | 41.78 | Upgrade
|
| P/OCF Ratio | 25.66 | 23.60 | 26.67 | 24.75 | 21.88 | 18.47 | Upgrade
|
| EV/Sales Ratio | 8.73 | 6.09 | 4.82 | 6.98 | 6.72 | 4.53 | Upgrade
|
| EV/EBITDA Ratio | 25.88 | 18.30 | 15.23 | 19.18 | 18.82 | 13.38 | Upgrade
|
| EV/EBIT Ratio | 37.10 | 24.53 | 18.99 | 21.81 | 20.69 | 14.89 | Upgrade
|
| EV/FCF Ratio | 36.56 | 33.98 | - | 36.00 | 22.94 | 39.97 | Upgrade
|
| Debt / Equity Ratio | 0.86 | 0.86 | 0.40 | 0.05 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 3.26 | 4.13 | 1.66 | 0.19 | 0.04 | 0.03 | Upgrade
|
| Debt / FCF Ratio | 4.61 | 7.79 | - | 0.36 | 0.05 | 0.11 | Upgrade
|
| Asset Turnover | 0.46 | 0.37 | 0.56 | 0.65 | 0.70 | 0.68 | Upgrade
|
| Inventory Turnover | 2.99 | 2.47 | 2.90 | 2.49 | 2.95 | 2.30 | Upgrade
|
| Quick Ratio | 0.59 | 0.70 | 1.22 | 1.99 | 1.78 | 2.10 | Upgrade
|
| Current Ratio | 1.07 | 0.91 | 1.73 | 3.14 | 2.80 | 2.91 | Upgrade
|
| Return on Equity (ROE) | 13.09% | 14.59% | 18.12% | 23.29% | 24.72% | 24.06% | Upgrade
|
| Return on Assets (ROA) | 6.71% | 5.77% | 8.87% | 12.92% | 14.30% | 12.95% | Upgrade
|
| Return on Capital (ROIC) | 7.97% | 6.78% | 10.31% | 14.76% | 16.70% | 15.16% | Upgrade
|
| Earnings Yield | 1.86% | 3.42% | 4.91% | 4.34% | 4.32% | 5.92% | Upgrade
|
| FCF Yield | 3.27% | 3.11% | -7.07% | 2.75% | 4.26% | 2.39% | Upgrade
|
| Dividend Yield | 0.00% | - | 1.28% | 0.88% | 0.93% | 0.80% | Upgrade
|
| Payout Ratio | 0.00% | - | 26.14% | 20.10% | 21.03% | 13.14% | Upgrade
|
| Buyback Yield / Dilution | -0.02% | -0.03% | -0.19% | -0.02% | 1.03% | 0.25% | Upgrade
|
| Total Shareholder Return | -0.02% | -0.03% | 1.10% | 0.86% | 1.96% | 1.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.